Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study

Bilici, Ahmet; Uysal, Mukremin; Menekse, Serkan; Akin, Semih; Yildiz, Fatih; Turan, Merve; Sezgin Goksu, Sema; Beypinar, Ismail; Sakalar, Teoman; Degirmenci, Mustafa; Erdem, Dilek; Basaran, Gul; Olmez, Omer Fatih; Avci, Nilufer; Tural, Deniz; Sakin, Abdullah; Turker, Sema; Demir, Atakan; Temiz, Suleyman; Kaplan, Muhammed Ali; Dogan, Mutlu; Tanriverdi, Ozgur; Bilgetekin, Irem; Cinkir, Havva Yesil; Acikgoz, Ozgur; Paydas, Semra; Uslu, Ruchan; Turhal, Serdar

doi:10.1080/07357907.2021.2017952

Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study

Date

2022

Authors

dc.identifier.doi

10.1080/07357907.2021.2017952

dc.identifier.other

WOS:000734258300001

Publisher

TAYLOR \& FRANCIS INC

DOI

10.1080/07357907.2021.2017952

Keywords

Everolimus , exemestane , metastatic breast cancer , hormone receptor\\-positive , HER \\- negative , efficacy

URI

https://openaccess.acibadem.edu.tr/handle/11443/7100

Collections

WOS

Full item page

Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By